Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017 having previously served as Chief Operating Officer from January 2014 to March 2017. Dr. Cutler served as Group President, Clinical Research Services from November 2011 until his appointment as Chief Operating Officer.  Dr. Cutler was appointed to the Board of Directors in November 2015. Prior to joining ICON, Dr. Cutler held the position of Chief Executive Officer of Kendle having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

 Cutler joined ICON in 2011 and is responsible for leading the company’s global operations, strategic customer alliances and the management of more than 460 clinical development projects from Phase IIb – IV. Steve has over 28 years of pharma and CRO experience.